Reports
Reports
Sale
The global nasogastric tube market size was valued at USD 505.1 million in 2023, driven by the increasing initiatives by pharma giants to develop the most effective cancer vaccine. The market is anticipated to grow at a CAGR of 5.3% during the forecast period of 2024-2032 to achieve a value of USD 804 million by 2032.
A nasogastric tube (NG tube) is a thin, flexible plastic tube which is typically used for temporary medical purposes. “Nasogastric” means “nose to stomach”. The tube is designed in such a way that it can pass through with ease and flexibility in nasal cavity to the throat and down through the oesophagus to stomach. There are various kind of nasogastric tubes used by healthcare providers to deliver substances to the stomach or vice versa.
Nasogastric tubes are used both to deliver substances to stomach and to draw substances out. It is used for temporary tube feeding and to deliver oral medications to the patients. The nasogastric tubes are also used to feed infants that are unable to intake nutrition by mouth. The two initial purposes of the nasogastric tube are short-term tube feeding and gastric suctioning. The placement of nasogastric tube in kids or in adults can be a bit tricky and may lead to different other problems in patients, if placed wrong.
The demand for nasogastric tubes has been rising and is likely to continue growing with the rising prevalence of chronic disorders, especially among the geriatric population across the globe. The rising emphasis and investment of key stakeholders in the research and development of technologically advanced nasogastric tube holders is expected to propel the global nasogastric tube market growth.
The prevalence of chronic diseases is growing at an alarming rate due to the sedentary lifestyles of the population. This is further aiding the demand for nasogastric tubes in the market. The opportunities for key players are also increasing due to the rising establishment and development of regulatory guidelines by regulatory bodies in North America. Due to poor appetite and deteriorating medical conditions, older people will face trouble consuming edibles and nutrition orally, directly contributing to the overall nasogastric tubes market share.
Additionally, the rising rates of hospitalization among children and the geriatric population is to directly contribute to the rising demand for these tubes because these nasogastric tubes are increasingly needed in hospitals for enabling enteral feeding, offering medicinal support, and gastric decompression of patients. The escalating awareness among people about the need for enteral nutrition instead of parenteral nutrition, along with shifting trends towards enteral feeding, will propel the nasogastric tubes market growth in future as well.
Market Breakup by Type
Market Breakup by Age Group
Market Breakup by End User
Market Breakup by Region
The increasing prevalence of chronic diseases, like cancer, diabetes, and cardiovascular disorders, respiratory and gastrointestinal diseases, is contributing to the global nasogastric tube market demand. These tubes are widely applicable in the decompression of the stomach in the setting of intestinal obstruction or ileus; however, they are also used to dispense nutrition or medication to patients who are incapable of oral consumption due to their condition. These tubes significantly speed up the treatment/ recovery process and thus are extremely useful. The product is also widely demanded in the healthcare sector to get the samples of the stomach contents of the patients in case of gastrointestinal disorders.
The rising prevalence of malnutrition can also be attributed to the global nasogastric tube market growth. The nasogastric tubes help in the feeding malnourished patients as most of the times the nutrition needs to be administered directly into their body.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Age Group |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Nasogastric Tube Market Overview
3.1 Global Nasogastric Tube Market Historical Value (2017-2023)
3.2 Global Nasogastric Tube Market Forecast Value (2024-2032)
4 Global Nasogastric Tube Market Landscape
4.1 Global Nasogastric Tube: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Nasogastric Tube: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Age Group
4.2.3 Analysis by Applications
5 Global Nasogastric Tube Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Nasogastric Tube Market Segmentation
6.1 Global Nasogastric Tube Market by Type
6.1.1 Market Overview
6.1.2 Levin Catheter
6.1.3 Dobhoff Tube
6.1.4 Sengstaken-Blakemore Tube
6.1.5 Others
6.2 Global Nasogastric Tube Market by Age Group
6.2.1 Market Overview
6.2.2 Adults
6.2.3 Pediatric
6.3 Global Nasogastric Tube Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Paediatric Clinics
6.3.4 Others
6.4 Global Nasogastric Tube Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Nasogastric Tube Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Nasogastric Tube Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Nasogastric Tube Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Nasogastric Tube Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Nasogastric Tube Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Andersen Products Inc.
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Bicakcilar A.S.
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 C.R. Bard Medical
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Degania Silicone Ltd.
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Pacific Hospital Supply Co. Ltd.
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Cardinal Health
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Guangdong Baihe Medical Technology
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Rontis Medical
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Poly Medicure Limited
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 SecurMed
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 505.1 million in 2023, driven by the increasing prevalence of chronic diseases globally.
The market is anticipated to grow at a CAGR of 5.30% during the forecast period of 2024-2032, likely to reach a market value of USD 804 million by 2032.
The rising awareness among people about the need for enteral nutrition and rising chronic diseases are among the major factors driving the market growth.
The increasing investment opportunities for key players as increase in implication of regulatory guidelines is expected to influence the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
Different types of nasogastric tube in the market include Levin Catheter, Dobhoff Tube, and Sengstaken-Blakemore Tube, among others.
The nasogastric tubes are widely used on adults and paediatrics.
End users in the market include hospitals and paediatric clinics, among others.
Key players involved in the market are Andersen Products Inc., Bicakcilar A.S., C.R. Bard Medical, Degania Silicone Ltd., Pacific Hospital Supply Co. Ltd., Cardinal Health, Guangdong Baihe Medical Technology, Rontis Medical, Poly Medicure Limited, and SecurMed.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.